Deakin University
Browse
- No file added yet -

Recalibrating the risks and benefits of lithium therapy

Download (378.22 kB)
Version 2 2024-05-30, 15:44
Version 1 2017-07-25, 14:49
journal contribution
posted on 2024-05-30, 15:44 authored by Michael BerkMichael Berk, S Cowdery, Lana WilliamsLana Williams, GS Malhi
Recent data might subtly recalibrate the risk/benefit ratio of lithium, the prototypical mood stabiliser for bipolar disorder. There are hints that lithium might be associated with a reduction in dementia risk and as noted in this Journal, a surprising reduction in the risk of cancer.

History

Journal

British journal of psychiatry

Volume

211

Pagination

1-2

Location

Cambridge, Eng.

Publisher DOI

Open access

  • Yes

Link to full text

ISSN

0007-1250

eISSN

1472-1465

Language

eng

Author URL

Publication classification

C4 Letter or note

Issue

1

Publisher

Cambridge University Press

Usage metrics

    Research Publications

    Categories

    No categories selected

    Keywords

    Antimanic AgentsBipolar DisorderDementiaHumansLithium CompoundsNeoplasmsScience & TechnologyLife Sciences & BiomedicinePsychiatryBIPOLAR DISORDERCANCERCOHORT110319 Psychiatry (incl Psychotherapy)920410 Mental HealthFaculty of HealthSchool of MedicineInnovation in Mental and Physical Health and Clinical Treatment3202 Clinical sciences

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC